Internal Medicine, Gastroenterology · Ann Arbor, MI
NPI
1003998535
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 E Medical Center Dr
Ann Arbor, MI, 48109
Phone (734) 936-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
137 services
Medicare patients, 2024
96
Average age 70
Drug cost, 2024
$1.3M
427 prescriptions
Company payments, 2023
$658
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John del Valle was code 99214 (office e&m - established), 49 times for 46 patients. In total John del Valle billed 137 services in 21 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 49 | 46 | $67.02 | $3,284 |
By year: 2022 $16K for 183 services; 2023 $16K for 178 services; 2024 $13K for 137 services.
Medicare prescription drug claims, 2024
In 2024, the drug John del Valle prescribed most often to Medicare patients was Famotidine, with 91 prescriptions and refills. In total John del Valle wrote 427 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 91 | 153 | 18 | $1,210 |
| Pantoprazole Sodium Generic | 49 | 75 | Under 11 | $1,581 |
| Omeprazole Generic | 35 | 99 | 14 | $574 |
| Humira(Cf) Pen Adalimumab | 24 | 24 | Under 11 | $295K |
| Azathioprine Generic | 23 | 69 | Under 11 | $2,081 |
| Mesalamine Generic | 21 | 54 | Under 11 | $25K |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 20 | 20 | 19 | $701 |
| Sandostatin Lar Depot Octreotide Acetate,mi-Spheres | 17 | 17 | Under 11 | $194K |
| Sulfasalazine Generic | 15 | 45 | Under 11 | $1,217 |
| Humira Adalimumab | 14 | 14 | Under 11 | $100K |
| Stelara Ustekinumab | 14 | 18 | Under 11 | $389K |
| Loperamide Loperamide Hcl | 11 | 11 | Under 11 | $579 |
| Sodium Chloride 0.9 % Sodium Chloride | 11 | 11 | Under 11 | $135 |
| Humira Pen Adalimumab | 11 | 11 | Under 11 | $150K |
Brand drugs: - claims; generic drugs: 291 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid John del Valle $658 ($658 in general payments such as food, travel and fees) from 1 company. The largest payer was Treace Medical Concepts, Inc. with $658.
| Company | Payments | Amount |
|---|---|---|
| Treace Medical Concepts, Inc. TMCI | 1 | $658 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.